Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis.
Buglione M, Pedretti S, Gipponi S, Buttolo L, Panciani P, Poliani PL, Liserre R, Borghetti P, Pegurri L, Costa L, Triggiani L, Pasinetti N, Ghirardelli P, Pandini S, Padovani A, Magrini SM; Neuro-Oncology Group, Spedali Civili Hospital and Brescia University. Buglione M, et al. Among authors: pegurri l. Radiol Med. 2015 Dec;120(12):1146-52. doi: 10.1007/s11547-015-0542-0. Epub 2015 Apr 28. Radiol Med. 2015. PMID: 25917339
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: Evolving technical choices and toxicity patterns.
Magrini SM, Tonoli S, Costa L, Pasinetti N, Paiar F, Livi L, Simontacchi G, Meattini I, Pegurri L, Borghetti P, Frata P, Ponticelli P, Buglione M, Biti G. Magrini SM, et al. Among authors: pegurri l. Radiol Med. 2012 Jun;117(4):715-24. doi: 10.1007/s11547-011-0756-8. Epub 2011 Nov 17. Radiol Med. 2012. PMID: 22095425
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.
Pegurri L, Buglione M, Girelli G, Guarnieri A, Meattini I, Ricardi U, Mangoni M, Gabriele P, Bellavita R, Krengli M, Bonetta A, Cagna E, Bunkheila F, Borghesi S, Signor M, Di Marco A, Bertoni F, Stefanacci M, Gatta R, De Bari B, Magrini SM. Pegurri L, et al. Tumori. 2014 Jan-Feb;100(1):31-7. doi: 10.1700/1430.15812. Tumori. 2014. PMID: 24675488
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease.
Costa L, Pedretti S, Foscarini F, Maddalo M, Pegurri L, Pasinetti N, Cavagnini R, Ciccarelli S, Tonoli S, Magrini SM, Buglione M. Costa L, et al. Among authors: pegurri l. Radiol Med. 2016 Jan;121(1):70-9. doi: 10.1007/s11547-015-0565-6. Epub 2015 Aug 1. Radiol Med. 2016. PMID: 26231252
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.
Pedretti S, Masini L, Turco E, Triggiani L, Krengli M, Meduri B, Pirtoli L, Borghetti P, Pegurri L, Riva N, Gatta R, Fusco V, Scoccianti S, Bruni A, Ricardi U, Santoni R, Magrini SM, Buglione M. Pedretti S, et al. Among authors: pegurri l. J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4. J Neurooncol. 2019. PMID: 31054101 Clinical Trial.
Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 Trial.
Maddalo M, Borghetti P, Tomasini D, Corvò R, Bonomo P, Petrucci A, Paiar F, Lastrucci L, Bonù ML, Greco D, Costa L, Pegurri L, Triggiani L, Belgioia L, Desideri I, Grisanti S, Buglione M, Magrini SM. Maddalo M, et al. Among authors: pegurri l. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):469-477. doi: 10.1016/j.ijrobp.2020.02.637. Epub 2020 Mar 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32184121 Clinical Trial.
19 results